How Has the Hematology Diagnostic Devices And Equipment Market Size Evolved in Recent Years?
The hematology diagnostic devices and equipment market has seen considerable growth due to a variety of factors.
• The market for hematology diagnostic devices and equipment has experienced swift expansion in recent times. Projected growth will see it increase from a value of $7.95 billion in 2024, to $9.04 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.7%.
The past growth in this sector can be credited to factors such as clinical diagnostics, blood banking, oncology and hematological disorders, as well as disease progression monitoring.
What are the Market Size and Expected Growth Rates for the Hematology Diagnostic Devices And Equipment Market?
The hematology diagnostic devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for hematology diagnostic devices and equipment is forecasted to increase consistently in the coming years, reaching $10.96 billion in 2029 with a 4.9% compound annual growth rate (CAGR). This expansion in the forecast period can be credited to factors such as an aging populace, personalized healthcare, the surge in blood-related diseases, and hematological biomarkers. The future trends predicted during this forecast period encompass improvements in technology, point-of-care hematology examinations, integration and automation, in addition to telemedicine and remote supervision.
Which Key Drivers Are Propelling The Hematology Diagnostic Devices And Equipment Market's Growth?
The surge in blood disorders is a significant driving force behind the popularity of hematology diagnostic devices. These devices are extensively utilized to determine the precise nature of any blood disorder. Blood disorders are conditions that influence the number of various types of blood cells, including red blood cells, white blood cells, and platelets. Regardless of age, race, or gender, blood disorders afflict millions of individuals worldwide every year. The World Health Organization, for instance, reports that the Hemoglobin disorder impacts 75% of all global births, and the occurrence of Anemia is about 12.7% in men.
What Are The Key Segments Within The Global Hematology Diagnostic Devices And Equipment Market?
The hematology diagnostic devices and equipment market covered in this report is segmented –
1) By Product: Instruments, Consumables
2) By Instruments: Analyzers, Flow cytometers, Other Instruments
3) By Consumables: Reagents, Stains, Other Consumables
4) By Application: Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications
5) By End User: Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes
Subsegments:
1) By Instruments: Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Hemoglobin Analyzers, Blood Gas Analyzers
2) By Consumables: Reagents, Test Strips, Blood Collection Tubes, Slides and Cover Slips, Others (calibration and quality control materials)
Pre-Book The Hematology Diagnostic Devices And Equipment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Hematology Diagnostic Devices And Equipment Industry?
There is a growing trend among hematology diagnostic device companies to invest in automation technology. The development of this technology is fueling the demand for hematology analyzers since it lowers the risk of errors found in manual procedures carried out in diagnostic centers. For instance, leading companies such as Sysmex have received a CLIA waiver for their new automated hematology analyzer. The selling of this product allows clinical facilities to conduct hematology tests without any manual inaccuracies. CLIA regulations set the quality standards for laboratory tests conducted on human samples like blood, body fluids, or tissues, meant for diagnosing, preventing diseases, or for health assessments.
Who Are the Key Players In The Hematology Diagnostic Devices And Equipment Market?
Major companies operating in the hematology diagnostic devices and equipment market include:
• Abbott Diagnostics
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Drucker Diagnostics Inc.
• Horiba Ltd.
• Instrumentation Laboratory Inc.
• Siemens Healthcare
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• F.Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• HemoCue AB
• Mindray Medical International Limited
• NORMA Group
• Danaher Corporation
• Edan Instruments Inc.
• Novo Nordisk
• Sysmex Corporation
• Fluidigm Corporation
• CellaVision
• Maccura Biotechnology Co.
• DY mind Biotech
• Balio Diagnostics
• BioSystems Diagnostics Pvt. Ltd.
• Wiener Lab
• Accurex Biomedical Pvt. Ltd.
• ARKRAY USA
• Boule Diagnostics AB
• DermaFlow
• Diagnostics Holdings
• Diatron Group
• EKF Diagnostics Holdings
• Grifols
• S.A.
• ICU Medical Inc.
• Nihon Kohden Corporation
• Ortho Clinical Diagnostics
• PixCell Medical
• STRATEC Biomedical AG
• Terumo BCT
• Z-Medica Corporation
What Are The Regional Insights Into The Hematology Diagnostic Devices And Equipment Market?
North America was the largest region in the global hematology diagnostics devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hematology diagnostics devices and equipment market. The regions covered in the hematology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
